Leung Kam
National Center for Biotechnology Information, NLM, NIH, Bethesda, MD,
Magnetic resonance imaging (MRI) maps information about tissues spatially and functionally. Protons (hydrogen nuclei) are widely used to create images because of their abundance in water molecules. Water comprises about 80% of most soft tissues. The contrast of proton MRI depends mainly on the density of nuclear (proton spins), the relaxation times of the nuclear magnetization (T1, longitudinal and T2, transverse), the magnetic environment of the tissues, and the blood flow to the tissues. However, insufficient contrast between normal and diseased tissues requires development of contrast agents. Most of the contrast agents affect the T1 and T2 relaxation of the surrounding nuclei, mainly the protons of water. T-2* is the spin-spin relaxation time composed of variations from molecular interactions and intrinsic magnetic heterogeneities of tissues in the magnetic field [1]. Superparamagnetic iron oxide (SPIO) structure is composed of ferric iron (Fe) and ferrous iron (Fe) in the general formula of FeOFeO. The iron oxides particles are coated with a layer of dextran or other polysaccharide. These particles have a large combined magnetic moments or spins which are randomly rotated in the absence of an applied magnetic field. SPIO is used mainly as a T2 contrast agent in MRI though it can shorten both T1 and T2/T2* relaxation processes. SPIO particle uptake into reticuloendothelial system is by endocytosis or phagocytosis. SPIO particles are taken up by phagocytic cells such as monocytes, macrophages, and oligodendroglial cells. A variety of cells can also be labeled with these particles for cell trafficking and tumor-specific imaging studies. SPIO agents are classified by their sizes with coating material (about 20 nm to 3,500 nm in diameters) as large SPIO agents (Ferumoxsil or AMI-121, Ferucarbotran, OMP), standard SPIO (SSPIO) agents (Ferumoxides or AMI-25, SHU 555A), ultrasmall SPIO (USPIO) agents (Ferumoxtran or AMI-227, NC100150) and monocrystalline iron oxide nanoparticles (MION) agents [1]. Ferumoxsil is composed of iron particles of about 10 nm and the hydrodynamic diameter is about 300 nm. The iron particles are coated with a non-biodegradable and insoluble matrix (siloxane) and suspended in viscosity-increasing agents such as starch and cellulose [2]. They are used in oral large SPIO preparations. Ferumoxsil has been tested in clinical trials as negative contrast agent that decreases signal on T2 images. Ferumoxsil is used in bowel MR imaging.
磁共振成像(MRI)在空间和功能上对组织信息进行映射。质子(氢原子核)因其在水分子中含量丰富而被广泛用于生成图像。水约占大多数软组织的80%。质子MRI的对比度主要取决于核(质子自旋)密度、核磁化的弛豫时间(T1,纵向;T2,横向)、组织的磁环境以及组织的血流情况。然而,正常组织与病变组织之间的对比度不足,需要研发造影剂。大多数造影剂会影响周围核的T1和T2弛豫,主要是水的质子。T - 2是由分子相互作用和磁场中组织的固有磁不均匀性变化组成的自旋 - 自旋弛豫时间[1]。超顺磁性氧化铁(SPIO)结构由三价铁(Fe)和二价铁(Fe)组成,通式为FeOFeO。氧化铁颗粒包覆有一层葡聚糖或其他多糖。这些颗粒具有大的合成磁矩或自旋,在没有外加磁场时随机旋转。SPIO在MRI中主要用作T2造影剂,尽管它可以缩短T1和T2/T2弛豫过程。SPIO颗粒通过内吞作用或吞噬作用被网状内皮系统摄取。SPIO颗粒被吞噬细胞如单核细胞、巨噬细胞和少突胶质细胞摄取。多种细胞也可以用这些颗粒进行标记,用于细胞转运和肿瘤特异性成像研究。SPIO制剂根据其大小和包覆材料(直径约20纳米至3500纳米)分为大SPIO制剂(Ferumoxsil或AMI - 121、Ferucarbotran、OMP)、标准SPIO(SSPIO)制剂(Ferumoxides或AMI - 25、SHU 555A)、超小SPIO(USPIO)制剂(Ferumoxtran或AMI - 227、NC100150)和单晶氧化铁纳米颗粒(MION)制剂[1]。Ferumoxsil由约10纳米的铁颗粒组成,流体动力学直径约为300纳米。铁颗粒包覆有不可生物降解且不溶性的基质(硅氧烷),并悬浮在增稠剂如淀粉和纤维素中[2]。它们用于口服大SPIO制剂。Ferumoxsil已在临床试验中作为降低T2图像信号的阴性造影剂进行测试。Ferumoxsil用于肠道MR成像。